ArticleExperimental and therapeutic medicine2015

Long-term remission induced by low-dose rituximab for relapsed and refractory thrombotic thrombocytopenic purpura: A report of two cases.

Hong-Yan Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.